VC  NanoDimension

http://www.nanodimension.com





     Office Locations:

2983 Woodside Road
Woodside, CA 94062
Phone: 650-241-1155
Fax: 650-529-1381

Get all office locations for this firm with a National Database subscription or Silicon Valley Database subscription.
 

Stages:

  • Early
  • Expansion
  • Growth
  • Seed


 

Industries:

  • Information Technology
  • Life Sciences & Healthcare

  •  

    Description:

    NanoDimension was started in 2002 with the goal of building a team of truly skilled scientists, investors and entrepreneurs to invest in and to support the growth and commercialization of nanotechnology. The firm targets breakthrough technologies at the nano-scale in the industries of: IT/electronics, life sciences, energy/materials, and the convergence of those three sectors. NanoDimension focuses on early to mid-stage investments, selectively seed and late-stage with an investment size ranging from a few thousand EURO up to EURO 8M per company (including follow-on investments). Typically, Nano-Dimension invests EURO 2M to EURO 5M over the lifetime of a company. The firm is primarily focused on Europe and North America, maintaining offices in Zurich and Silicon Valley.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Silicon Valley Database subscription.
    Aymeric Sallin Founder & CEO
    Eric Moessinger Principal
    Jonathan Nicholson Executive Director
    Kirill Kuzmichev Principal
    Richard Coles Director

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      08/31/2017


      ARMO Biosciences


      CA


      $67,000,000


      Series C-1


     

    Portfolio companies include:


      ARMO Biosciences
        web link


      BIND Biosciences
        web link


      Blend Therapeutics
        web link


      Crocus Technology
        web link


      Emulate
        web link


      Muse Bio
        web link


      SBA Materials
        web link


      Selecta
        web link


      Soladigm
        web link


      SQZ Biotech
        web link


      View Dynamic Glass
        web link


      Xtellus
        web link


     

    Recent News:


      There is no recent news for NanoDimension.